84 related articles for article (PubMed ID: 5365729)
1. [Induction of immune insufficiency in adult mice by the additive utilization of a non-specific stimulant of immune reactions and of immunosuppressive chemotherapy].
Amiel JL; Bérardet M
Rev Fr Etud Clin Biol; 1969 Nov; 14(9):912-5. PubMed ID: 5365729
[No Abstract] [Full Text] [Related]
2. [Trial of treatment of E male G 2 leukemia by a combination of chemotherapy and specific and non-specific immunotherapy].
Amiel JL; Bérardet M
Rev Fr Etud Clin Biol; 1969; 14(7):685-8. PubMed ID: 5354663
[No Abstract] [Full Text] [Related]
3. [Immunological treatment of leukemias].
Szmigiel Z
Pol Tyg Lek; 1971 Mar; 26(13):482-4. PubMed ID: 4929907
[No Abstract] [Full Text] [Related]
4. Prolongation of rat skin allograft survival with isonicotinic acid hydrazide and methapyrilene hydrochloride.
Moore TC; Thompson DP
Surg Gynecol Obstet; 1971 Feb; 132(2):275-83. PubMed ID: 4396059
[No Abstract] [Full Text] [Related]
5. [Pharmacological susceptibility of cellular immunity].
Floersheim GL
Z Naturwiss Med Grundlagenforsch; 1965 Oct; 2(4):307-60. PubMed ID: 5887477
[No Abstract] [Full Text] [Related]
6. Potentiation of a cyclophosphamide-induced immunodepression by the administration of BCG.
Mathé G; Halle-Pannenko O; Bourut C
Transplant Proc; 1974 Dec; 6(4):431-3. PubMed ID: 4612894
[No Abstract] [Full Text] [Related]
7. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive action in mice of diazoacetylglycine amide and diazoacetylglycine hydrazide in compairison to methotrexate].
Baldini L; Brambilla G; Cavanna M; Parodi S
Boll Soc Ital Biol Sper; 1968 Mar; 44(5):441-3. PubMed ID: 5674631
[No Abstract] [Full Text] [Related]
9. Effect of methylhydrazine derivatives on the survival of second-set skin homografts.
Floersheim GL
Nature; 1966 Aug; 211(5049):638-9. PubMed ID: 5338821
[No Abstract] [Full Text] [Related]
10. [Attempts at active non-specific immunotherapy using formolized Corynebacterium parvum].
Amiel JL; Litwin J; Bérardet M
Rev Fr Etud Clin Biol; 1969 Nov; 14(9):909-12. PubMed ID: 5365728
[No Abstract] [Full Text] [Related]
11. More immunosuppressives needed.
Nature; 1969 Mar; 221(5183):805-6. PubMed ID: 5765049
[No Abstract] [Full Text] [Related]
12. [The immunosuppressive agents. VI. Immunosuppressive action of anti-lymphocyte serums].
Renoux M; Mikol C
Presse Med (1893); 1967 Oct; 75(43):2167-70. PubMed ID: 6053126
[No Abstract] [Full Text] [Related]
13. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
Kato K; Yamamoto K
Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cell-mediated alloimmunity by BCG. II. Induction of specific, nonadherent, non-T-killer cells by BCG and alloantigen.
Murahata RI; Mitchell MS
J Natl Cancer Inst; 1982 Sep; 69(3):613-8. PubMed ID: 6810008
[TBL] [Abstract][Full Text] [Related]
15. [Search for tumor-specific immune reactions in leukemias in humans by the indirect membrane immunofluorescence technic].
Pasternak G; Micheel B; Pasternak L; Blau HJ; Kruse H
Arch Geschwulstforsch; 1970; 35(4):360-8. PubMed ID: 4932082
[No Abstract] [Full Text] [Related]
16. Computerized quantitation of immunosuppressive synergy for clinical protocol design.
Chou TC; Stepkowski SM; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3043-5. PubMed ID: 7940955
[No Abstract] [Full Text] [Related]
17. [Immunological aspects of leukemia].
Kornhuber B
Monatsschr Kinderheilkd (1902); 1970 Jan; 118(1):20-1. PubMed ID: 5523508
[No Abstract] [Full Text] [Related]
18. Deoxycoformycin (pentostatin): clinical pharmacology, role in the chemotherapy of cancer, and use in other diseases.
Spiers AS
Haematologia (Budap); 1996; 27(2):55-84. PubMed ID: 14651224
[TBL] [Abstract][Full Text] [Related]
19. [Effect of pasteurization on the immunosuppressive activity of the alpha-globulin fraction in blood plasma].
Bednarík T; Cajthamlová H; Novák JT
Cesk Farm; 1981 Jun; 30(5):166-8. PubMed ID: 6170465
[No Abstract] [Full Text] [Related]
20. Leucyl-leucine methyl ester-treated haploidentical donor lymphocyte infusions can mediate graft-versus-leukemia activity with minimal graft-versus-host disease risk.
Hsieh MH; Varadi G; Flomenberg N; Korngold R
Biol Blood Marrow Transplant; 2002; 8(6):303-15. PubMed ID: 12108916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
